An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Procedure: Surgeries
- Registration Number
- NCT03413956
- Lead Sponsor
- Jiangsu Cancer Institute & Hospital
- Brief Summary
The real-world observational study was designed to explore the odd factors of lymph metastases in the patients with T1 non-small cell lung cancer, the effects of clinical characteristics on lymph metastases, and compare the differences in lymph metastases in the subgroups.
- Detailed Description
The trial is a multi-centre, real-world non-interventional observational study. In the study, the patients with T1 non-small cell lung cancer enrolled in clinics from 2015 to 2017 were included via a retrospectively review method and the study data on patient demographic/tumor biological characteristics, and clinical treatments were collected to explore the clinical odd factors of lymph metastases, evaluate the effects of clinical characteristics on lymph metastases, and compare the differences in lymph metastases in the subgroups.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10885
- Patients who received surgeries from 2015 to 2017;
- Pathologically diagnosed patients with T1 non-small cell lung cancer;
- Patients with tumor treatments (including chemotherapies, radiotherapies, biological therapies, intervention therapies)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description NSCLC patients with lymph metastases Surgeries Pathologically diagnosed patients with T1 non-small cell lung cancer complicated with lymph metastases after surgeries
- Primary Outcome Measures
Name Time Method Percentage of the patients with lymph metastases 2015 - 2017 Percentages of the patients with lymph metastases categorised by patient demographic and tumor biological characteristics
- Secondary Outcome Measures
Name Time Method Percentages of N0/N1/N2/N3 patients 2015 - 2017 Percentages of N0/N1/N2/N3 patients in the target population
Trial Locations
- Locations (10)
China-Japan Friendship Hospital
🇨🇳Beijing, Beijing, China
China People's Liberation Army Hospital
🇨🇳Beijing, Beijing, China
Henan cancer hospital
🇨🇳Zhengzhou, Henan, China
Tongji Hospital Affiliated to Tongji Medical College, Huaxi Technology University
🇨🇳Wuhan, Hubei, China
First Hospital Affiliated to Medical College, Zhejiang University
🇨🇳Hangzhou, Zhejiang, China
Xi'an Tangdu Hospital
🇨🇳Xi'an, Shaanxi, China
Shanghai Chest Hospital
🇨🇳Shanghai, Shanghai, China
Henan Cancer Hospital
🇨🇳Zhengzhou, Henan, China
West China Hospital
🇨🇳Chengdu, Sichuan, China
Jiangsu Cancer Institute and Hospital
🇨🇳Nanjing, Jiangsu, China